Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
13-valent pneumococcal conjugate vaccine (PCV13) in preterm versus term infants.
Federico Martinón-Torres, Hanna Czajka, Kimberly J. Center, Jacek Wysocki, Ewa Majda-Stanislawska, Felix Omeñaca, Enrique Bernaola Iturbe, Daniel Blazquez Gamero, Ana Concheiro-Guisán, Francisco Gimenez-Sanchez, Leszek Szenborn, Peter C. Giardina, Scott Patterson, William C. Gruber, Daniel A. Scott, Alejandra Gurtman
Journal:
Pediatrics
Publicación independiente
Impact factor
5.359
Q1
Vaccine evaluation: lessons from a meningococcal B vaccine.
Sarfatti A, Martinón-Torres F, Nadel S
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.041
Q1
Should the Indication of Pneumococcal Polysaccharide Vaccine in Children Be Definitively Withdrawn?
Federico Martinón Torres
Journal:
Clin Infect Dis
Publicación independiente
Impact factor
8.313
Q1
Rotavirus vaccination in Europe: drivers and barriers.
N Parez, C Giaquinto, C Du Roure, F Martinon-Torres, V Spoulou, P Van Damme, T Vesikari
Journal:
Lancet Infect Dis
Publicación independiente
Impact factor
24.446
Q1
RSV—Still More Questions Than Answers
Louis Bont, Eugenio Baraldi, Brigitte Fauroux, Anne Greenough, Terho Heikkinen, Paolo Manzoni, Federico Martinón-Torres, Harish Nair and Nikolaos G. Papadopoulos, on behalf of ReSViNET
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Prognostic markers of meningococcal disease in children: recent advances and future challenges.
María Montero-Martín, David P Inwald, Enitan D Carrol & Federico Martinón-Torres
Journal:
Expert Rev Infect Ther
Publicación independiente
Impact factor
3.767
Q1
Pneumococcal Vaccination in Europe: Schedule Adherence
Alain Gervaix; Filippo Ansaldi; Antonio Brito-Avô; Chiara Azzari, Markus Knuf; Federico Martinón-Torres; David Tuerlinckx; Myint TinTin Htar, and George A. Syrogiannopoulos
Journal:
Clin Therap
Publicación independiente
Impact factor
3.119
Q2
Overuse of bronchodilators and steroids in bronchiolitis of different severity Bronchiolitis-study of variability, appropriateness, and adequacy
C. Ochoa Sangrador, J. González de Dios, Research Group of the aBREVIADo Project
Journal:
Allergol Immunopathol (Madr)
Publicación independiente
Impact factor
1.276
Q3
Year:
2014
Doi:
Caracterización microbiológica de las gastroenteritis agudas virales atendidas en un servicio de pediatría en un área de alta cobertura vacunal frente a rotavirus
Carlos García-Magán, María José de Castro-López, José Llovo-Taboada, Carmen Curros-Novo, Miriam Puente-Puig, Alicia Sánchez-Fauquier, Federico Martinón-Torres
Journal:
Enferm Infecc Microbiol Clin
Publicación independiente
Impact factor
1.654
Q3
Evolving Role of 13-valent Pneumococcal Conjugate Vaccine in Clinical Practice
Azzari C, Martinón-Torres F, Schmitt HJ, Dagan R.
Journal:
Pediatr Infect Dis J.
Publicación independiente
Impact factor
2.126
Q2
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Jacobo Pardo-Seco, Federico Martinón-Torres and Antonio Salas
Journal:
BMC Genomics
Publicación independiente
Impact factor
3.594
Q2
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome
Jan De Waele, Jeffrey Lipman, Yasser Sakr, John C Marshall, Philippe Vanhems, Casiano Barrera Groba, Marc Leone, Jean-Louis Vincent and for the EPIC II Investigators
Journal:
BMC Infec Dis
Publicación independiente
Impact factor
2.688
Q3
Year:
2014
Doi:
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study
Thierry Gustot, Peter Felleiter, Peter Pickkers, Yasser Sakr, Jordi Rello, Dimitrios Velissaris, Charalampos Pierrakos, Fabio S. Taccone, Pavel Sevcik, Christophe Moreno, Jean-Louis Vincent and for the EPIC II Group of Investigators
Journal:
Liver Internat.
Publicación independiente
Impact factor
5.175
Q1
Year:
2014
Doi:
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants.
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe,Javier Diez-Domingo, Qin Jiang, John L. Perez
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
Fe de errores de «Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes»
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
A Genome-Wide Study of Modern-Day Tuscans: Revisiting Herodotus’s Theory on the Origin of the Etruscans
Jacobo Pardo-Seco, Alberto Gómez-Carballa, Jorge Amigo, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Prevención de la enfermedad meningocócica por el serogrupo B mediante una vacuna de 4 componentes
A. Gil, D. Barranco, J. Batalla, J.M. Bayas, M. Campins, P. Gorrotxategi Gorrotxategi, J. Lluch, F. Martinon-Torres, M.J. Mellado, D. Moreno-Pérez, B. Uriel, J.A. Vázquez
Journal:
An Pediatr
Publicación independiente
Impact factor
1.313
Q4
Immunisation against meningococcus B: the case of Spain
Federico Martinón Torres
Journal:
Lancet
Publicación independiente
Impact factor
60.392
Q1
Read my lips: oral manifestations of systemic diseases.
de Castro López MJ, Illade Quinteiro L, Martinón Torres F, Cutrín Prieto JM.
Journal:
Journal of Pediatrics
Publicación independiente
Impact factor
3.700
Q1
Dr. Google: what about the human papillomavirus vaccine?
Leticia Pías-Peleteiro, Javier Cortés-Bordoy, and Federico Martinón-Torres
Journal:
Human Vaccines & Immunother
Publicación independiente
Impact factor
2.619
Q2
Adaptive support ventilation: State of the art review.
Fernández J, Miguelena D, Mulett H, Godoy J, Martinón-Torres F.
Journal:
Indian J Crit Care Med
Publicación independiente
Impact factor
Indian Signatures in the Westernmost Edge of the European Romani Diaspora: New Insight from Mitogenomes
Alberto Gómez-Carballa, Jacobo Pardo-Seco, Laura Fachal, Ana Vega, Miriam Cebey, Nazareth Martinón-Torres, Federico Martinón-Torres, Antonio Salas
Journal:
PLoS ONE
Publicación independiente
Impact factor
2.740
Q2
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes.
Jethro A. Herberg, Myrsini Kaforou, Stuart Gormley, Edward R. Sumner, Sanjay Patel, Kelsey D. J. Jones, Stéphane Paulus, Colin Fink, Federico Martinon-Torres, Giovanni Montana, Victoria J. Wright, and Michael Levin
Journal:
J. Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule
Gail L. Rodgersa, Susanna Esposito, Nicola Principi, Maricruz Gutierrez-Brito, Javier Diez-Domingo, Andrew J. Pollard, Matthew D. Snape,Federico Martinón-Torres, William C. Gruber, Scott Patterson, Allison Thompson,Alejandra Gurtman, Peter Paradiso, Daniel A. Scott
Journal:
Vaccine
Publicación independiente
Impact factor
3.143
Q2
No results found.
Considerations on the clinical application of the human papillomavirus vaccine in Spain
Javier Cortés, Federico Martinon-Torres, José Manuel Ramón, Cajal, Gabriel Ferret and Angel Gil
Doi:
Human Vaccines
Factor de impacto:
Q2
Doi:
Circovirus and impact of temporary withdrawal of rotavirus vaccines in Spain
Marta Bouzón Alejandro, Javier Diez Domingo and Federico Martinón Torres
Doi:
Human Vaccines
Factor de impacto:
Q2
Doi:
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett; Elie Azoulay; Pablo M. Echeverria; Jean-Louis Vincent; and for the Extended Prevalence of Infection in the ICU Study (EPIC II) Group of Investigators (F. Martinón-Torres)
Doi:
Crit Care Med.
Factor de impacto:
Q1
Doi:
Acute lung injury in children: Therapeutic practice and feasibility of international clinical trials
Santschi M, Jouvet P, Leclerc F, Gauvin F, Newth CJ, Carroll CL, Flori H, Tasker RC, Rimensberger PC, Randolph AG; for the PALIVE Investigators, the Pediatric Acute Lung Injury and Sepsis Investigators Network (PALISI); the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) (Martinón-Torres F).
Doi:
Ped Crit Care Med
Factor de impacto:
Q1
Doi:
The Spanish human papillomavirus vaccine consensus group: A working model
Javier Cortés & Federico Martinón-Torres; Spanish HPV Vaccine Consensus Group.
Doi:
Human Vaccines
Factor de impacto:
Q2
Doi:
Multicenter prospective study analysing the role of rotavirus on acute gastroenteritis in Spain
Gimenez-Sanchez F, Delgado-Rubio A, Martinon-Torres F, Bernaola-Iturbe E; Rotascore Research Group.
Doi:
Acta Pediatr
Factor de impacto:
Q1
Doi:
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease
Davila S, Wright VJ, Khor CC, Sim KS, Binder A, Breunis WB, Inwald D, Nadel S, Betts H, Carrol ED, de Groot R, Hermans PW, Hazelzet J, Emonts M, Lim CC, Kuijpers TW, Martinon-Torres F, Salas A, Zenz W, Levin M, Hibberd ML; International Meningococcal Genetics Consortium.
Doi:
Nature Genetics
Factor de impacto:
Q1
Doi:
Estudio de variabilidad en el abordaje de la bronquiolitis aguda en España en relación con la edad de los pacientes
J. González de Dios, C. Ochoa Sangrador, Grupo Investigador del Proyecto aBREVIADo (BRonquiolitis-Estudio de Variabilidad, Idoneidad, ADecuación) (F. Martinón-Torres)
Doi:
An Pediatr
Factor de impacto:
Q4
Doi:
Prevención primaria y secundaria de los cánceres de cuello de útero y vulva: recomendaciones para la práctica clínica
Cortes J, Martinón-Torres F, Ramon, Cajal JM, Gil A, Velasco J, Abizanda, Miranda P, Garrido R.
Doi:
Prog Obstet Ginecol
Factor de impacto:
Doi:
Neumomediastino espontáneo primario
Moure J.D., Muñiz M., Martinón-Torres F., Trabazo S., Martinón Sánchez JM
Doi:
Pneuma
Factor de impacto:
Doi:
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Pediatr Infect Dis J
Factor de impacto:
Doi: